US Patent 9096549 Selective HDAC3 inhibitors
Patent 9096549 was granted and assigned to Acetylon Pharmaceuticals, Inc. on August, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+155 characters)
Article
Patent abstract
Provided herein are HDAC3 inhibitors, as well as methods of treatment comprising administering these compounds to a subject in need thereof.
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09096549 Selective HDAC3 inhibitors US Patent 9096549 Selective HDAC3 inhibitors
Infobox
Patent Number
0909654900
Patent Number
909654900
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
090965490
Date of Patent
August 4, 2015
0Patent Application Number
141697320
Date Filed
January 31, 2014
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
090965490
Date of Patent
August 4, 2015
0Patent Application Number
141697320
Date Filed
January 31, 2014
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09096549 Selective HDAC3 inhibitors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09096549
Date of patent
August 4, 2015
Patent application number
14169732
Date Filed
January 31, 2014
Patent primary examiner
Find more entities like US Patent 9096549 Selective HDAC3 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
